Dr. Richard J Dipaolo's lab at Saint Louis University focuses on understanding how chronic inflammation in the stomach leads to precancerous conditions and ultimately gastric cancer. The research investigates the roles of specific immune cells and cytokines in the development of gastric metaplasia—a state that increases cancer risk. By using mouse models and human tissue samples, the lab aims to identify potential targets for new preventive and therapeutic strategies against gastric diseases.

Dr. Sarah Blutt's lab at Baylor College of Medicine focuses on studying the effects of high-dose radiation on the human gastrointestinal system using advanced models called human intestinal organoids. By recreating human intestinal environments in the lab, they aim to understand how radiation damages the gut and to develop potential therapies to aid recovery. This research is particularly important for creating effective treatments to protect against damage from radiation exposure during nuclear emergencies.

Dr. Rachelle Gaudet's lab at Harvard University studies membrane proteins, which are crucial for helping cells communicate and transport substances. By using techniques like X-ray crystallography and advanced microscopy, the lab investigates how these proteins work, particularly in bacteria. The research has important implications for drug development and understanding how bacteria adapt to their environments.

Dr. Yongsheng Shi's lab at UC Irvine focuses on understanding the processes that control how genes are expressed at the molecular level, particularly through mechanisms called alternative polyadenylation (APA) and alternative splicing. The research is particularly interested in how these processes affect B cell development and function, which are critical for the immune response. By uncovering the regulatory networks involved, the lab aims to provide insights that could lead to improved treatments for autoimmune diseases and cancer.

Dr. Sankar Ghosh's lab focuses on understanding the underlying mechanisms of diseases like Inflammatory Bowel Disease and Alzheimer's Disease. By investigating genetic factors and molecular pathways, the lab aims to identify potential therapeutic targets. Through studies on long noncoding RNAs and mitochondrial function, they seek to reveal how these elements contribute to disease susceptibility and progression.

Scott C. Dawson's lab at UC Davis studies the mechanisms of how the Giardia lamblia parasite attaches to the intestines. They are particularly focused on a unique organelle called the ventral disc, which allows Giardia to adhere to the intestinal wall, causing diseases like diarrhea. By using advanced imaging and genetic tools, the lab aims to uncover how this attachment occurs and to find potential treatments against Giardia infections.

Dr. Tatyana Golovkina's lab at the University of Chicago investigates how certain retroviruses interact with the immune system and the microbiota to influence viral infections and cancer development. They focus on understanding the regulation of immune responses by a special molecule called H2-O and exploring how gut bacteria can promote or impede the progression of leukemia induced by viruses. Their research aims to uncover new mechanisms that could improve vaccinations and therapeutic strategies against viral infections and cancer.

Andrew L Goodman's lab at Yale University studies the complex interactions between our gut microbiome and the food we eat. They focus on how different diets influence microbial communities in our intestines and how these microbes, in turn, affect our health, specifically in relation to food-borne infections. By understanding these interactions, the lab aims to find ways to improve health outcomes and fight infections caused by pathogens like Salmonella and Campylobacter.

Rachel Gottschalk's lab at the University of Pittsburgh focuses on understanding how immune cells in the lungs, specifically alveolar macrophages, function during both health and infection. The lab investigates how signaling molecules in the lung environment influence the behavior of these immune cells, which can help improve treatments for infections and chronic lung diseases. By studying specific genes and signaling pathways, the research aims to shed light on how to better control inflammation and immune responses in the lungs.

Dr. Michael Stephen Trent's lab at the University of Georgia focuses on understanding how Gram-negative bacteria, like Acinetobacter baumannii, develop their protective outer membrane. The research aims to uncover the mechanisms behind the transport and assembly of essential membrane components, which is crucial due to the rising threat of antibiotic resistance. The findings could lead to innovative strategies for designing new antimicrobial treatments that target these formidable pathogens.

Dr. Hongyan Guo's lab focuses on understanding how the herpes simplex virus type 1 (HSV-1) manipulates host cell death processes to spread during infection. They study a specific protein called ZBP1, which is involved in the programmed cell death pathway that helps control viral infections. By uncovering the mechanisms behind ZBP1's actions and its interaction with viral components, the lab aims to reveal new insights that could lead to better therapies against HSV-1 and similar viruses.

Dr. Venkatakrishna Rao Jala's lab focuses on understanding how gut barrier dysfunction contributes to inflammatory bowel diseases (IBD) like ulcerative colitis and Crohn's disease. They are investigating a compound called Urolithin A (UroA), which shows promise in enhancing gut barrier function and reducing inflammation. Their research aims to uncover the mechanisms by which UroA activates specific cellular pathways to provide potential treatments for IBD.

Dr. Andreas J. Baumler's lab focuses on understanding the complex interactions between gut microbiota, host health, and infectious diseases. Their research includes studying how probiotics like E. coli Nissle 1917 protect against infections from pathogens such as Salmonella, examining the impact of gut microbiota changes on chronic kidney disease, and probing the links between diet, gut bacteria, and inflammatory bowel disease. The lab employs a range of innovative techniques to uncover the mechanisms that maintain gut health and combat various diseases.

Dr. Eric C. Martens' lab at the University of Michigan focuses on how dietary factors, particularly fiber and soy protein, influence gut health and the prevention of inflammatory bowel disease (IBD). They utilize mouse models to investigate the interactions between the gut microbiome and the mucus barrier, aiming to uncover mechanisms that could mitigate the risk of IBD. Their research could ultimately lead to better dietary recommendations and treatments for gut-related diseases.

Dr. Liang Zhou's research lab focuses on understanding how specific immune cells in the gut, particularly RORgt+ lymphocytes, maintain tissue health and respond to infections. The lab investigates the roles of mitochondrial function and iron metabolism in the upkeep and activity of these immune cells, which could lead to new treatments for diseases like inflammatory bowel disease and infections. By exploring the intricate relationships between these cells and their environment, the research aims to uncover mechanisms that are crucial for gut health and immunity.

Dr. Ivaylo Ivanov's lab at Columbia University studies the role of specific immune cells in the gut and how they contribute to obesity and related metabolic diseases. By understanding how certain gut bacteria influence immune responses, the lab aims to uncover new ways to prevent and treat conditions like diabetes and inflammatory bowel disease. The research focuses on the connection between diet, gut immunity, and overall health.

Dr. Christophe O. Benoist's lab focuses on understanding how T regulatory cells (Tregs) in the gut are maintained and shaped by the microbiome and food antigens. The lab investigates the role of Tregs in preventing inflammation and autoimmunity, particularly in the context of the IPEX syndrome, a condition related to faulty Treg function. Through a combination of advanced genetic techniques and single-cell analysis, the lab seeks to map the pathways that define Treg behavior and how they interact with their environment.

Dr. Brady L Spencer's lab at the University of Virginia explores how certain bacteria can disrupt the balance of the gut microbiome, especially in newborns. Their research focuses on Group B Streptococcus (GBS), a bacterium that can lead to severe infections in infants. The lab studies how GBS uses specific proteins to damage the gut lining, alter immune responses, and potentially cause systemic infections. Understanding these mechanisms aims to improve our knowledge of treatment and prevention strategies for neonatal infections.

Dr. Vanessa Sperandio's lab at the University of Wisconsin-Madison studies how gut bacteria and host signals regulate disease-causing bacteria, specifically enterohemorrhagic E. coli (EHEC). The lab focuses on understanding how neurotransmitters like norepinephrine and endocannabinoids affect the virulence of these pathogens and their interactions with the gut microbiota. This research is important for understanding microbial infections and developing better treatments against enteric diseases.

Dr. Karen M. Haas leads a research lab focused on understanding how aging and biological sex influence the immune response to pneumococcal vaccines, particularly in elderly populations. Her work aims to identify why older adults, especially males and females, respond differently to vaccines against Streptococcus pneumoniae, a bacterium responsible for serious infections. By studying these differences, her lab seeks to improve vaccine design to effectively protect this at-risk group against pneumonia and other complications.